Are Pivotal Trials for Drugs Approved for Leukemia, Myelodysplastic Syndromes, and Multiple Myeloma Representative of the Population Demographics Affected By These Diseases?

Category Systematic review
JournalBLOOD
Year 2021
This article has no abstract
Epistemonikos ID: 8389299e58f7b0dacc53e8846d6a99e9e090db7e
First added on: Feb 13, 2025